[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.82.105. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 603
Citations 0
Lab Reports
October 6, 2015

Study Elucidates How Antidepressants May Lessen Neuropathic Pain

JAMA. 2015;314(13):1331. doi:10.1001/jama.2015.12352

Tricyclic antidepressants (TCAs) and selective serotonin-norepinephrine reuptake inhibitors that are prescribed to treat patients with depression are also known to alleviate chronic neuropathic pain, but the mechanisms are not fully understood.

Now, researchers at the Icahn School of Medicine at Mount Sinai in New York City and their colleagues have discovered that the TCA desipramine may alleviate neuropathic pain by modulating specific cellular signaling events in the nucleus accumbens (NAc), a part of the brain’s reward system (Mitsi V et al. Proc Natl Acad Sciences. doi:10.1073/pnas.1504283112 [published online August 24, 2015]).

First Page Preview View Large
First page PDF preview
First page PDF preview
×